↓ Skip to main content

Time for a general approval of growth hormone treatment in adults with Prader–Willi syndrome

Overview of attention for article published in Orphanet Journal of Rare Diseases, February 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Time for a general approval of growth hormone treatment in adults with Prader–Willi syndrome
Published in
Orphanet Journal of Rare Diseases, February 2021
DOI 10.1186/s13023-020-01651-x
Pubmed ID
Authors

Charlotte Höybye, Anthony J. Holland, Daniel J. Driscoll

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 13%
Unspecified 2 6%
Student > Postgraduate 2 6%
Student > Master 2 6%
Librarian 1 3%
Other 3 10%
Unknown 17 55%
Readers by discipline Count As %
Sports and Recreations 3 10%
Medicine and Dentistry 3 10%
Nursing and Health Professions 2 6%
Social Sciences 2 6%
Unspecified 1 3%
Other 0 0%
Unknown 20 65%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 February 2021.
All research outputs
#7,302,290
of 24,333,504 outputs
Outputs from Orphanet Journal of Rare Diseases
#1,022
of 2,866 outputs
Outputs of similar age
#176,940
of 517,873 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#31
of 89 outputs
Altmetric has tracked 24,333,504 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 2,866 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 517,873 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.